Adapalene and benzoyl peroxide topical gel 0.1%/2.5% (Actavis Mid-Atlantic LLC)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adapalene and benzoyl peroxide topical gel 0.1%/2.5% (Actavis Mid-Atlantic LLC), covering 2011-12-29 to 2011-12-29. Get the full timeline:
Most recent: Clinical Trial Update: A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris [NA]